Limited Capacity available for July 2026!

De-risk market access.

Accelerate portfolio revenue.

You back the innovation.

We build the scalable business.

Buoyancy Health Strategy bridges the gap between technical excellence and healthcare adoption. We partner with HealthTech and MedTech investors to accelerate market entry, optimise business models, and provide fractional C-suite commercial leadership that turns portfolio companies into scalable, fundable market leaders.

Schedule a portfolio review

How we create value for your portfolio

Entering complex healthcare systems is notorious for slow adoption, institutional friction, and wasted capital.

We transform reactive go-to-market efforts into focused, system-aligned execution:

Accelerated market access

We break through healthcare system friction by aligning portfolio products directly with health system priorities and defining clear adoption pathways.

Capital-efficient commercialisation

We turn innovations into fundable businesses by designing health-specific business models and go-to-market plans and scaling revenue without the immediate overhead of full-time senior hires.

We identify and activate new revenue streams, assess international markets for strategic fit, and align product portfolios to real-world clinical demand.

Targeted revenue expansion

Precision support across the investment journey

Early-stage / Post-seed

Go-to-Market & traction

How we move the needle:

Designing scalable health-specific business models and crafting value propositions that land with clinical decision-makers and economic buyers.

Pre-deal / seed

Valuation & diligence

How we move the needle:

Commercial and market reality checks incl. revenue projections, reimbursement pathways, and NHS/health system adoption timelines before you deploy capital.

Exits & restructuring

Commercial optimisation

How we move the needle:

Supporting post-merger integration (PMI) for commercial directorates, optimising capabilities, and aligning organisational structures for scale.

Growth / Series A+

Expansion & scaling

How we move the needle:

Prioritising international market entry, identifying new B2B/B2G revenue streams, and aligning product portfolios to sustained market demand.

Our track record of scalable growth

2x revenue growth and NHS adoption

We assisted a medical device start-up in re-engineering their go-to-market strategy, directly securing NHS adoption, scaling operations, and doubling revenue.

5-year global capital allocation strategy

We conducted a global market analysis for a leading diagnostics company to identify high-margin expansion opportunities and focus investment priorities for a 5-year growth horizon.

Commercial post-merger integration

We led the post-merger integration for the commercial directorate of a national healthcare organisation, aligning roles, structural shape, and commercial capabilities.

Why investors partner with us

What sets Buoyancy Health Strategy apart is our ability to combine commercial strategy with deep health system insider knowledge:

Over 15 years of sector expertise

Proven track record as a business strategist and consulting professional across MedTech, HealthTech, and pharma.

Buyer-side leadership experience

Direct executive leadership positions within NHS acute hospital providers and Integrated Care Boards (ICBs /payer organisations). We know how healthcare buyers evaluate risk, allocate budget, and adopt innovation.

Delivered projects across twelve countries in Europe, the Middle East, and Southeast Asia, bringing an international perspective to market expansion.